ÂÜÀòÂÒÂ×

Lynda Boutemeur currently serves as a CRA II at ICON plc since June 2024, following a role as CRA Lead at ARCAGY-GINECO from April 2022 to June 2024, where Lynda managed a Phase III trial on metastatic cervical cancer treatments. Lynda's previous experiences include positions as a clinical research associate and monitor, and notable involvement in regulatory affairs during an internship at Sanofi. With a background in pharmacy from the Faculté de médecine Ben Youcef Ben Khedda and a Master’s degree in Clinical Research Coordination from De Vinci Executive Education, Lynda possesses extensive knowledge in pharmacology, drug management, and toxicology. Additionally, Lynda has engaged in diverse roles, including sales management and professional coaching, alongside a competitive sports career in Taekwondo.